Brii Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SEHK:2137 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
13 Dec 24	BuyHK$44,880	Zhi Hong	Individual	50,000	HK$0.90
12 Dec 24	BuyHK$137,349	Zhi Hong	Individual	151,500	HK$0.91
11 Dec 24	BuyHK$20,184	Zhi Hong	Individual	21,500	HK$0.94
25 Nov 24	BuyHK$20,514	Zhi Hong	Individual	20,500	HK$1.00
22 Nov 24	BuyHK$29,016	Zhi Hong	Individual	28,500	HK$1.02
21 Nov 24	BuyHK$18,745	Zhi Hong	Individual	18,000	HK$1.04
25 Sep 24	BuyHK$41,141	Zhi Hong	Individual	39,000	HK$1.05
24 Sep 24	BuyHK$74,692	Zhi Hong	Individual	71,000	HK$1.05
24 Sep 24	SellHK$51,881	Ankang Li	Individual	49,500	HK$1.05
23 Sep 24	BuyHK$59,131	Zhi Hong	Individual	58,000	HK$1.02
20 Sep 24	BuyHK$40,338	Zhi Hong	Individual	41,500	HK$0.97
26 Aug 24	SellHK$1,455	Ankang Li	Individual	1,500	HK$0.97

Insider Trading Volume

Insider Buying: 2137 insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 2137?
Owner Type	Number of Shares	Ownership Percentage
Institutions	7,272,670	0.995%
Individual Insiders	35,190,647	4.81%
VC/PE Firms	162,430,030	22.2%
General Public	526,300,709	72%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 16 shareholders own 28.02% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.4%	Arch Venture Partners, L.P.	90,410,418	HK$76.8m	0%	1.02%
9.85%	Boyu Capital Group Management Ltd.	72,019,612	HK$61.2m	0%	0.99%
4.54%	Zhi Hong	33,181,690	HK$28.2m	0.88%	no data
0.8%	Zhonggeng Fund Management Co., Ltd.	5,878,500	HK$5.0m	0%	0.02%
0.2%	Ankang Li	1,442,957	HK$1.2m	0%	no data
0.11%	GF Fund Management Co., Ltd.	800,000	HK$680.0k	0%	no data
0.066%	Dimensional Fund Advisors LP	480,871	HK$408.8k	0%	no data
0.03%	Taiyin Yang	218,000	HK$185.3k	100%	no data
0.015%	American Century Investment Management Inc	112,000	HK$95.2k	0%	no data
0.012%	Yiu Wa Tsui	87,000	HK$74.0k	19.2%	no data
0.012%	Gregg Alton	87,000	HK$74.0k	19.2%	no data
0.012%	Martin J. Murphy	87,000	HK$74.0k	19.2%	no data
0.012%	Hui Tang	87,000	HK$74.0k	19.2%	no data
0.00007%	UBS Asset Management AG	500	HK$435.1	0%	no data
0.00007%	Purekind Fund Management Co.,Ltd.	500	HK$435.1	0%	no data
0.00004%	Norges Bank Investment Management	299	HK$248.6	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/23 14:37
End of Day Share Price	2024/12/23 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Brii Biosciences Limited is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Wangbin Zhou	China International Capital Corporation Limited
Xiao Wei Lin	Everbright Securities Co. Ltd.
Geoffrey Porges	Leerink Partners LLC